UHS
Universal Health Services Inc Health Care Services-General Medical & Surgical Hospitals, NEC S&P 500Russell 3000
$176.05Close
$141.00 – $243.1252-week range
Jan 26, 2027Next report · estimated
Highlights
Cautions
- Not in an uptrend 1 of 8 trend conditions
- Lagging the market RS 36 · weaker than 64% of stocks over 12 months
- Far from its high 28% below its 52-week high
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Key figures
Off 12-month high
28%
1wk
down 5.8%
price change
1mo
up 1.0%
price change
12-month return
down 19%
market up 11% ·
its own down 32%
F-score
—
— Not assessed
Altman Z″
3.54
Low risk
P/E
—
price / earnings
PEG
—
P/E / EPS growth
P/B
—
price / book
Earnings yield
—
EBIT / enterprise value
Cheaper than
—
of the market · not assessed
Revenue growth
up 10%
year on year
EPS growth
up 10%
latest quarter · -8 pts
Sales growth
up 8%
latest quarter · -1 pts
ROE
up 21%
return on equity
Free cash margin
up 5%
$849.2M FCF
D/E
0.55
long-term debt / equity
Net debt / EBITDA
1.5×
Interest cover
12.8×EBIT / interest
Piotroski tests
Repair signals
- Long-term debt down 10% ($4.5B → $4.0B)
Trade setup
ATR%
3.5%
$6.11 a day · 2×ATR $163.83
RS
36 / 99
vs the universe
Trend
1 / 8
trend template
Relative volume
0.8×
vs 50-day average
Up/down volume
0.90
50 sessions
Implied move
—
no scheduled report
Trend template · 1 of 8
- 50-day average above the 150 and 200-day: passes
Screen verdict
Did not qualify for any screen.
Warning signs
- No restatement or impairment
- Equity positive
- Interest covered
- No material dilution
- Profits tracking cash
- Margins and revenue not shrinking
Last reported
Oct 27, 2026
Results reaction
Oct 27, 2026-8% vs market2 sessions after results
Options
$13,43532.8% IV · activity
Financials
- Net 9%
- Free cash 5%
- Cash
- Long-term debt
| FY2020Dec 31, 2020 | FY2021Dec 31, 2021 | FY2022Dec 31, 2022 | FY2023Dec 31, 2023 | FY2024Dec 31, 2024 | FY2025Dec 31, 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $11.6B | $12.6B | $13.4B | $14.3B | $15.8B | $17.4B |
| Operating income | $1.4B | $1.4B | $1.0B | $1.2B | $1.7B | $2.0B |
| Net income | $944.0M | $991.6M | $675.6M | $717.8M | $1.1B | $1.5B |
| Net margin | 8% | 8% | 5% | 5% | 7% | 9% |
| Earnings per share | $11.03 | $11.85 | $9.15 | $10.24 | $16.82 | $23.10 |
| Free cash flow | $1.6B | $28.0M | $262.0M | $524.7M | $1.1B | $849.2M |
| Free cash margin | 14% | 0% | 2% | 4% | 7% | 5% |
| Cash | $1.2B | $115.3M | $102.8M | $119.4M | $126.0M | $137.8M |
| Long-term debt | $3.5B | $4.1B | $4.7B | $4.8B | $4.5B | $4.0B |
| Shareholders' equity | $6.3B | $6.1B | $5.9B | $6.1B | $6.7B | $7.3B |
What options price now
- Expected 1-month range The at-the-money straddle for the expiry nearest a month out, as a share of the price: the move, either way, the option market is pricing by then. The range is the price plus and minus that move; the stock ends inside it a little more often than not. Methodology
- $164 – $188 ±6.7% by Nov 20, 2026
- Swings expected vs recent The daily swings the options are priced for (implied volatility) against the swings the stock actually had over the last 20 sessions (realised volatility). Bigger means options charge for more movement than the stock has been delivering; smaller, less. On a contract row, that contract's own implied volatility over the stock's realised. Methodology
- About the same 32.8% priced · 31.3% recent
- Next month vs later At-the-money implied volatility for 8-45 day expiries over 46-90 day ones: whether options price the coming month as choppier or calmer than the two after it. Ahead of a report it usually reads choppier, and the extra comes out once the report is out. Methodology
- Choppier
- Crash protection What options that pay off in a fall cost against options that pay off in a rise (the 25-delta skew), compared with this company's own normal - the median of its stored nightly readings, once there are 20 - and with five sessions ago. Protection costs a little more than upside on most shares. More than usual means readers of the chain are paying up to insure against a drop; it does not say which way the stock will go. Methodology
- past week: costs more
Positioning
- Premium traded
- $13,435 calls $6,415 · puts $7,020 · latest session
- 1.09× +0.93 over the week
- Open interest added The change over five sessions in option positions left open overnight, calls and puts. A rise means positions were added. It cannot say whether they were bought or sold, so more calls is not a vote for a rise: a call is as often sold against shares already held. Methodology
- calls +444 · puts +2.26k past week
For options traders: ATM IV 32.8% (-5.3% 1w) · 1m ÷ 3m IV 1.11 · 25Δ skew 5.0 pts · Net GEX $411,071
Most traded contracts
No contract passed the liquidity filters this week.
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| Aug 7, 2026 | Quarterly ↗ | Jun 30, 2026 | 38d |
| May 7, 2026 | Quarterly ↗ | Mar 31, 2026 | 37d |
| Feb 25, 2026 | Annual ↗ | Dec 31, 2025 | 56d |
| Nov 7, 2025 | Quarterly ↗ | Sep 30, 2025 | 38d |
| Aug 8, 2025 | Quarterly ↗ | Jun 30, 2025 | 39d |
| May 8, 2025 | Quarterly ↗ | Mar 31, 2025 | 38d |
| Feb 26, 2025 | Annual ↗ | Dec 31, 2024 | 57d |
| Nov 8, 2024 | Quarterly ↗ | Sep 30, 2024 | 39d |
| Aug 8, 2024 | Quarterly ↗ | Jun 30, 2024 | 39d |
| May 8, 2024 | Quarterly ↗ | Mar 31, 2024 | 38d |
| Feb 27, 2024 | Annual ↗ | Dec 31, 2023 | 58d |
| Nov 8, 2023 | Quarterly ↗ | Sep 30, 2023 | 39d |
Current reports
| Filed | Disclosed |
|---|---|
| Oct 27, 2026 | Results ↗ |
| Aug 21, 2026 | Material agreement · New obligation ↗ |
| Aug 17, 2026 | New obligation · Other events ↗ |
| Aug 13, 2026 | Material agreement ↗ |
| Jul 28, 2026 | Results ↗ |
| Jul 21, 2026 | Material agreement · New obligation ↗ |
| May 22, 2026 | Shareholder vote ↗ |
| May 21, 2026 | Director or officer change ↗ |
| Apr 28, 2026 | Results ↗ |
| Apr 24, 2026 | Material agreement · New obligation ↗ |
| Mar 30, 2026 | Director or officer change ↗ |
| Mar 9, 2026 | Other events ↗ |